Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

April 1998

Cost of Migraine Management: A Pharmacoeconomic Overview

ByAlan M. Rapoport, MD,James U. Adelman, MD

April 1st 1998

A Program to Reduce Discharge Delays in a Neonatal Intensive Care Unit

ByDeborah F. Perlmutter, RN, NP,Chona Suico, RN,Alfred N. Krauss, MD,Peter A. M. Auld, MD

April 1st 1998

Attitudes and Behavioral Intentions Regarding Managed Care: A Comparison of Academic and Community Physicians

ByGarrett E. Foulke, MD,Robert A. Bell, PhD,Allan D. Siefkin, MD,Richard L. Kravitz, MD, MSPH

April 1st 1998

Physician and Dietitian Prescribing of a Commercially Available Oral Nutritional Supplement

ByCarrie Steigh, MPH, RD,Peter A. Glassman, MBBS, MSc,Felicitas Fajardo, MA, RD, FADA

April 1st 1998

A New Gatekeeper for Back Pain

ByAlan D. Horwitz, DC,Ronald Hosek, PhD, DC, MPH,Joseph Boyle, DC, DABCN, FICC,Arnold Cianciulli, MS, DC,Jon Glass, MD,Ronald Codario, MD

April 1st 1998

Influencing Physicians: The Three Critical Elements of a Successful Strategy

ByHarry L. Leider, MD, MBA

April 1st 1998

Alzheimer's Disease: Clinical Features and Pharmacologic Management

ByAndrea S. Franks, PharmD, BCPS,W. Nathan Rawls, PharmD

April 1st 1998

Medicare HMOs: Who Joins and Who Leaves?

ByBeth A. Virnig, PhD, MPH,Robert O. Morgan, PhD,Carolee A. DeVito, PhD, MPH,Nancy Alfred Persily, MPH

April 1st 1998

Changes in Benefit Payments and Health Insurance Premiums Among Firms Switching Health Insurance Carriers

ByThomas M. Wickizer, PhD,Karen M. Travis, PhD,Paul J. Feldstein, PhD

April 1st 1998

Trending on AJMC

Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD

frontMIND Trial Shows PFS Benefit With Tafasitamab, Lenalidomide Combo in High-Risk DLBCL: Umberto Vitolo, MD